ArticleBMC public health2026
The refinement of drug safety governance based on contradiction matrix.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
aimsThe contradiction matrix in the field of general engineering was introduced into the field of drug safety governance, and the contradiction matrix in the refinement of drug safety governance was constructed to provide innovative ideas for solving the problem of drug safety governance, so as to promote the refinement of drug safety governance and ensure the safety of drug use.
methodsFirstly, the problems of different governance subjects in drug safety governance were sorted out from the perspective of co-governance by multiple subjects. Secondly, the problem was parameterized, and the sorted problems were transformed into corresponding parameters for representation, and 18 parameters for refinement of drug safety governance were obtained. Thirdly, the contradiction matrix in the refinement of drug safety governance was constructed by combining 40 innovative principles. Finally, the practical application steps and application effects of the contradiction parameters and the contradiction matrix were discussed through case analysis.
resultsThe results show that the constructed parameters in the refinement of drug safety governance can better represent the problem attributes existing in drug safety governance, and the constructed contradiction matrix can provide innovative ideas for drug safety governance.
conclusionThe contradiction matrix can be used to analyze the problems existing in the refinement of drug safety management preferably, and match the specific problems with management parameters. The conflict matrix constructed and 40 invention principles are used to solve practical problems, so as to provide decision-making help and innovative ideas to solve problems for drug safety governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.